-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integra Lifesciences Holdings Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Integra Lifesciences Holdings Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$2.86 M, a 246% decline year-over-year.
- Integra Lifesciences Holdings Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$11.9 M, a 159% decline from 2022.
- Integra Lifesciences Holdings Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$4.59 M, a 66.4% decline from 2021.
- Integra Lifesciences Holdings Corp annual Deferred Income Tax Expense (Benefit) for 2021 was -$2.76 M, a 95.7% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)